These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 15461232)

  • 1. Did President Reagan have mild cognitive impairment while in office? Living longer with Alzheimer's Disease.
    Sherman FT
    Geriatrics; 2004 Sep; 59(9):11, 15. PubMed ID: 15461232
    [No Abstract]   [Full Text] [Related]  

  • 2. Alzheimer's disease and cognitive impairment.
    Connelly B
    Front Aging Ser; 1988; 6():167-78. PubMed ID: 10318123
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study.
    Chiu CC; Su KP; Cheng TC; Liu HC; Chang CJ; Dewey ME; Stewart R; Huang SY
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1538-44. PubMed ID: 18573585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioplex analysis of plasma cytokines in Alzheimer's disease and mild cognitive impairment.
    Lee KS; Chung JH; Lee KH; Shin MJ; Oh BH; Hong CH
    Immunol Lett; 2008 Dec; 121(2):105-9. PubMed ID: 18930766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's. A dignity in dementia.
    Cowley G
    Newsweek; 2001 Sep; 138(12):58. PubMed ID: 11573364
    [No Abstract]   [Full Text] [Related]  

  • 6. Underwriting Alzheimer's dementia.
    Iacovino JR
    J Insur Med; 1991; 23(1):47-48. PubMed ID: 10171643
    [No Abstract]   [Full Text] [Related]  

  • 7. Maximizing the Alzheimer's Disease Neuroimaging Initiative II.
    Carrillo MC; Sanders CA; Katz RG
    Alzheimers Dement; 2009 May; 5(3):271-5. PubMed ID: 19362888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation--a pharmacological fMRI study.
    Goekoop R; Scheltens P; Barkhof F; Rombouts SA
    Brain; 2006 Jan; 129(Pt 1):141-57. PubMed ID: 16251213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF APPs alpha and phosphorylated tau protein levels in mild cognitive impairment and dementia of Alzheimer's type.
    Fellgiebel A; Kojro E; Müller MJ; Scheurich A; Schmidt LG; Fahrenholz F
    J Geriatr Psychiatry Neurol; 2009 Mar; 22(1):3-9. PubMed ID: 19073834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropathology of older persons without cognitive impairment from two community-based studies.
    Bennett DA; Schneider JA; Arvanitakis Z; Kelly JF; Aggarwal NT; Shah RC; Wilson RS
    Neurology; 2006 Jun; 66(12):1837-44. PubMed ID: 16801647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's Gains fuel optimism.
    Vickery K
    Provider; 2004 Aug; 30(8):33-5. PubMed ID: 15384309
    [No Abstract]   [Full Text] [Related]  

  • 12. Deeply affected. As the nation ages, Alzheimer's will strike more people close to us.
    Naditz A
    Contemp Longterm Care; 2003 Jul; 26(7):20-2, 24. PubMed ID: 12891804
    [No Abstract]   [Full Text] [Related]  

  • 13. Evolution of blood pressure in patients with Alzheimer's disease: a one year survey of a French Cohort (REAL.FR).
    Hanon O; Latour F; Seux ML; Lenoir H; Forette F; Rigaud AS;
    J Nutr Health Aging; 2005; 9(2):106-11. PubMed ID: 15791354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stress and coping in older people with Alzheimer's disease.
    de Souza-Talarico JN; Chaves EC; Nitrini R; Caramelli P
    J Clin Nurs; 2009 Feb; 18(3):457-65. PubMed ID: 19077019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The public's perceptions about cognitive health and Alzheimer's disease among the U.S. population: a national review.
    Anderson LA; Day KL; Beard RL; Reed PS; Wu B
    Gerontologist; 2009 Jun; 49 Suppl 1():S3-11. PubMed ID: 19525214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3D comparison of hippocampal atrophy in amnestic mild cognitive impairment and Alzheimer's disease.
    Apostolova LG; Dinov ID; Dutton RA; Hayashi KM; Toga AW; Cummings JL; Thompson PM
    Brain; 2006 Nov; 129(Pt 11):2867-73. PubMed ID: 17018552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 10-item smell identification scale related to risk for Alzheimer's disease.
    Tabert MH; Liu X; Doty RL; Serby M; Zamora D; Pelton GH; Marder K; Albers MW; Stern Y; Devanand DP
    Ann Neurol; 2005 Jul; 58(1):155-60. PubMed ID: 15984022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlations between cognition and function in Alzheimer's disease: based on the abbreviated Barcelona Test (a-BT)].
    Peña-Casanova J; Monllau A; Böhm P; Blesa González R; Aguilar Barberà M; Sol JM; Hernández G;
    Neurologia; 2005; 20(1):4-8. PubMed ID: 15704015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered expression of zinc transporters-4 and -6 in mild cognitive impairment, early and late Alzheimer's disease brain.
    Smith JL; Xiong S; Markesbery WR; Lovell MA
    Neuroscience; 2006 Jul; 140(3):879-88. PubMed ID: 16580781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired verb fluency: a sign of mild cognitive impairment.
    Ostberg P; Fernaeus SE; Hellström K; Bogdanović N; Wahlund LO
    Brain Lang; 2005 Nov; 95(2):273-9. PubMed ID: 16246735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.